Close Menu

CHICAGO (GenomeWeb) – Early results from a prospective study by investigators at Ambry Genetics, Beth Israel Deaconess Medical Center, the University of Pittsburgh, and HonorHealth/TGen suggest that the suite of genes that carry risky mutations in some pancreatic cancer patients may be broader than generally appreciated.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.


This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.